Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurent P Rivory

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
RNA (New York, N.Y.)|December 23, 2009
Intended transcriptional silencing with siRNA results in gene repression through sequence-specific off-targetingJoshua Moses, Amber Goodchild, Laurent P Rivory
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 4, 2005
Rapid quantitation of plasma 2'-deoxyuridine by high-performance liquid chromatography/atmospheric pressure chemical ionization mass spectrometry and its application to pharmacodynamic studies in cancer patientsKong M Li, Laurent P Rivory, Stephen J Clarke
The Lancet. Oncology|April 12, 2003
Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapyKellie A Slaviero, Stephen J Clarke, Laurent P Rivory
Seminars in Oncology|February 7, 2003
Pemetrexed: single-agent and combination phase I study overviewMichael J Boyer, Laurent P Rivory, Stephen J Clarke
The Medical Journal of Australia|February 14, 2002
Clinical pharmacologyGillian M Shenfield, David G Le Couteur, Laurent P Rivory
Nutrition and Cancer|December 24, 2003
Baseline nutritional assessment in advanced cancer patients receiving palliative chemotherapyKellie A Slaviero, Jane A Read, Stephen J Clarke, et al.
Oncology Reports|April 8, 2004
Effect of short-term morphine exposure on P-glycoprotein expression and activity in cancer cell linesMarina Pajic, Mary Bebawy, Janelle M Hoskins, et al.
British Journal of Clinical Pharmacology|July 11, 2006
Altered deoxyuridine and thymidine in plasma following capecitabine treatment in colorectal cancer patientsKong M Li, Laurent P Rivory, Janelle Hoskins, et al.
British Journal of Clinical Pharmacology|March 18, 2004
Population pharmacokinetics of raltitrexed in patients with advanced solid tumoursElaine Y L Blair, Laurent P Rivory, Stephen J Clarke, et al.
Oncology Reports|October 10, 2003
The relative contributions of carboxylesterase and beta-glucuronidase in the formation of SN-38 in human colorectal tumoursPeter J Tobin, Helen M Dodds, Stephen Clarke, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
RNA (New York, N.Y.)|December 23, 2009
Intended transcriptional silencing with siRNA results in gene repression through sequence-specific off-targetingJoshua Moses, Amber Goodchild, Laurent P Rivory
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 4, 2005
Rapid quantitation of plasma 2'-deoxyuridine by high-performance liquid chromatography/atmospheric pressure chemical ionization mass spectrometry and its application to pharmacodynamic studies in cancer patientsKong M Li, Laurent P Rivory, Stephen J Clarke
The Lancet. Oncology|April 12, 2003
Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapyKellie A Slaviero, Stephen J Clarke, Laurent P Rivory
Seminars in Oncology|February 7, 2003
Pemetrexed: single-agent and combination phase I study overviewMichael J Boyer, Laurent P Rivory, Stephen J Clarke
The Medical Journal of Australia|February 14, 2002
Clinical pharmacologyGillian M Shenfield, David G Le Couteur, Laurent P Rivory
Nutrition and Cancer|December 24, 2003
Baseline nutritional assessment in advanced cancer patients receiving palliative chemotherapyKellie A Slaviero, Jane A Read, Stephen J Clarke, et al.
Oncology Reports|April 8, 2004
Effect of short-term morphine exposure on P-glycoprotein expression and activity in cancer cell linesMarina Pajic, Mary Bebawy, Janelle M Hoskins, et al.
British Journal of Clinical Pharmacology|July 11, 2006
Altered deoxyuridine and thymidine in plasma following capecitabine treatment in colorectal cancer patientsKong M Li, Laurent P Rivory, Janelle Hoskins, et al.
British Journal of Clinical Pharmacology|March 18, 2004
Population pharmacokinetics of raltitrexed in patients with advanced solid tumoursElaine Y L Blair, Laurent P Rivory, Stephen J Clarke, et al.
Oncology Reports|October 10, 2003
The relative contributions of carboxylesterase and beta-glucuronidase in the formation of SN-38 in human colorectal tumoursPeter J Tobin, Helen M Dodds, Stephen Clarke, et al.
Pageof 3